Literature DB >> 3109620

Treatment of palindromic rheumatism with chloroquine.

P Hanonen, T Möttönen, M Oka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109620      PMCID: PMC1246455          DOI: 10.1136/bmj.294.6582.1289

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  7 in total

1.  Treatment of palindromic rheumatism with D-penicillamine.

Authors:  E C Huskisson
Journal:  Br Med J       Date:  1976-10-23

2.  D-penicillamine in palindromic rheumatism.

Authors:  D N Golding
Journal:  Br Med J       Date:  1976-12-04

3.  Prophylactic colchicine therapy in palindromic rheumatism.

Authors:  M Schwartzberg
Journal:  J Rheumatol       Date:  1982 Mar-Apr       Impact factor: 4.666

4.  Palindromic rheumatism. Clinical and serum complement study.

Authors:  M A Wajed; D L Brown; H L Currey
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

5.  Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls.

Authors:  M Yunus; A T Masi; J J Calabro; K A Miller; S L Feigenbaum
Journal:  Semin Arthritis Rheum       Date:  1981-08       Impact factor: 5.532

6.  Preliminary criteria for clinical remission in rheumatoid arthritis.

Authors:  R S Pinals; A T Masi; R A Larsen
Journal:  Arthritis Rheum       Date:  1981-10

7.  Palindromic rheumatism.

Authors:  S Mattingly; D W Jones; W M Robinson; R A Williams; E C Dunn
Journal:  J R Coll Physicians Lond       Date:  1981-04
  7 in total
  4 in total

1.  Palindromic rheumatism in Israel--a disease entity? A survey of 34 patients.

Authors:  A Eliakim; L Neumann; J Horowitz; D Buskila; A Kleiner-Baumgarten; S Sukenik
Journal:  Clin Rheumatol       Date:  1989-12       Impact factor: 2.980

Review 2.  Can rheumatoid arthritis be prevented?

Authors:  Kevin D Deane
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-10-02       Impact factor: 4.098

Review 3.  Pathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLE.

Authors:  Kevin D Deane; Hani El-Gabalawy
Journal:  Nat Rev Rheumatol       Date:  2014-02-11       Impact factor: 20.543

Review 4.  Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemic.

Authors:  Bogna Grygiel-Górniak
Journal:  Clin Rheumatol       Date:  2021-07-03       Impact factor: 3.650

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.